Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06838689 · ClinicalTrials.gov registry record · NA

Participatory Approaches to Qualitative Research (PAQ): Comparing Two Approaches to Patient, Public and Clinician Involvement in Qualitative Research

A NA study of Cancer Screening and Serious Illness, sponsored by Dartmouth-Hitchcock Medical Center.

Recruiting
Registry status
NA
Development phase
136
Enrollment target
2
Study locations

NCT06838689: Recruiting NA study of Cancer Screening and Serious Illness, sponsored by Dartmouth-Hitchcock Medical Center.

NCT06838689 is a NA study of Cancer Screening and Serious Illness that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 136 participants, below the 653-participant average among 4 other Cancer Screening trials with a reported enrollment target (79% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06838689, a NA study of Cancer Screening and Serious Illness, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.

RECRUITING
Registry status
NA
Development phase
136 participants
Enrollment target
2
Study locations

Study Summary

The goal of this trial is to compare two types of patient, public and clinician involvement (PPCI) in research: Consultative PPCI and Collaborative PPCI. The study team will compare these methods of PPCI in a randomized clinical trial (RCT) in which PPCI participants will engage with research teams on one of three real qualitative research interview studies addressing topics: 1) pediatric mental health, 2) cancer screening and 3) serious illness. Qualitative interviews are conversations with people about their experiences and perspectives. In all three qualitative studies, PPCI participants will help us at every stage of the research, from design (making choices about how to set up the study) through dissemination (sharing findings). The researchers do not know about any quantitative (numbers) evidence from RCTs about how well different PPCI approaches work. As far as the study team knows, this is the first RCT of PPCI approaches. Given this gap in knowledge, the research question is: How does a Consultative PPCI approach compare to a Collaborative PPCI approach in increasing engagement and partnership trust in research, particularly among historically underrepresented groups? The researchers' best guess (hypothesis), considering the information available, is that Collaborative PPCI will increase PPCI participant engagement, trust and the patient-centeredness of research more than Consultative PPCI.

Primary Outcome

Engagement in research, measured using the Patient Engagement in Research scale (PEIRS-22). Total score is 22-110, with higher scores reflecting greater engagement in research.

Interventions

  • OTHER Comparison of two standard of care regimens

Study Locations (2)

New Hampshire

  • Geisel School of Medicine at Dartmouth - Hanover
  • Dartmouth-Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2025-09-01
Est. Completion 2027-10-31
Phase NA
Dartmouth-Hitchcock Medical Center

427 total trials

What NCT06838689 shows while recruiting

NCT06838689 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 653-participant average among 4 other Cancer Screening trials with a reported enrollment target (79% lower).

The record links to 3 conditions, with Cancer Screening appearing as the primary indexed condition, and to 1 intervention - of which Comparison of two standard of care regimens is the first listed.

NCT06838689 reports a single indexed study location in New Hampshire.

Frequently Asked Questions

What is clinical trial NCT06838689 about?

NCT06838689 is a clinical study titled "Participatory Approaches to Qualitative Research (PAQ): Comparing Two Approaches to Patient, Public and Clinician Involvement in Qualitative Research". The goal of this trial is to compare two types of patient, public and clinician involvement (PPCI) in research: Consultative PPCI and Collaborative PPCI. The study team will compare these methods of PPCI in a randomized clinical trial (RCT) in which PPCI participants will engage with research teams...

What is the current status of trial NCT06838689?

This trial is currently recruiting. It is a NA study. The enrollment target is 136 participants. The study started on 2025-09-01. Estimated completion is 2027-10-31.

What conditions does trial NCT06838689 study?

This clinical trial studies the following conditions: Cancer Screening, Serious Illness, Pediatric Mental Health Services.

What interventions are being tested in trial NCT06838689?

The interventions under investigation include: Comparison of two standard of care regimens (OTHER).

Who is sponsoring clinical trial NCT06838689?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06838689 being conducted?

This trial has 2 study locations across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01555892 · 136 participants · Phase 1

    Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

  • NCT03216525 · 136 participants · Phase 3

    Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

  • NCT04476901 · 136 participants · Phase 2

    Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy

  • NCT04603898 · 136 participants · NA

    Oxalate Formation From Ascorbic Acid

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06838689, the US trial registry maintained by the National Library of Medicine. NCT06838689 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.